Yale Study Identifies ‘Major Player’ in Skin Cancer Genes
A multidisciplinary team at Yale, led by Yale Cancer Center members, has defined a subgroup of genetic mutations that are present in a significant number of melanoma skin cancer cases. Their findings shed light on an important mutation in this deadly disease, and may lead to more targeted anti-cancer therapies.
Yale Cancer Center/Smilow Cancer Hospital is one of the 26 NCCN Member Institutions.
...
Source: National Comprehensive Cancer Network - Category: Cancer & Oncology Source Type: news
More News: Cancer | Cancer & Oncology | Cancer Therapy | Genetics | Hospitals | Melanoma | Skin | Skin Cancer | Study | Yale